Alimera sciences reports second quarter 2023 results

Atlanta, aug. 10, 2023 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the second quarter of 2023.

ALIM Ratings Summary

ALIM Quant Ranking